SEC Form D private-offering filing

Monocacy Therapeutics Inc.

Name: Monocacy Therapeutics Inc. - new SEC Form D private-offering filing, Monrovia, MD
Published: 2026-05-27

A new SEC Form D private-offering notice from Monrovia, MD, an undisclosed offering target in Biotech. The source filing is one click away.

Monocacy Therapeutics Inc. Verified via SEC Form D

Monrovia, Maryland based biotechnology company pursuing AI guided discovery and development of immune medicines for cancer and autoimmune disease.

Filed 2026-05-27Filed to raise UndisclosedFirst money in 2026-05-05Raised so far $114,450HQ (as filed) Monrovia, MDSector Biotech ✓Stage (inferred) Pre-seedCall status Delayed filing

Source linked the Form D on EDGAR↗Named in the filing 1 executive & director

Open this row on the live feed →More new filings in Maryland →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.